{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T03:56:50Z","timestamp":1780372610125,"version":"3.54.1"},"reference-count":125,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bprclinrheum.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.berh.2016.10.004","type":"journal-article","created":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T03:15:56Z","timestamp":1478747756000},"page":"870-888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Lung involvement in inflammatory rheumatic diseases"],"prefix":"10.1016","volume":"30","author":[{"given":"Clive","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kundan","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La'ali","family":"Iman-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanchan","family":"Manchegowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2016.10.004_bib1","series-title":"Rheumatoid arthritis: the management of rheumatoid arthritis in adults","author":"National Institute for Health and Clinical Excellence","year":"2009"},{"key":"10.1016\/j.berh.2016.10.004_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/09059180.00008014","article-title":"Rheumatoid arthritis-associated lung disease","volume":"24","author":"Shaw","year":"2015","journal-title":"Eur Respir Rev"},{"issue":"11","key":"10.1016\/j.berh.2016.10.004_bib3","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.autrev.2013.05.001","article-title":"Lung involvement in connective tissue diseases: a comprehensive review and a focus on rheumatoid arthritis","volume":"12","author":"Marigliano","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.berh.2016.10.004_bib4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ejim.2013.07.004","article-title":"Rheumatoid arthritis (RA) associated interstitial lung disease (ILD)","volume":"24","author":"O'Dwyer","year":"2013","journal-title":"Eur J Int Med"},{"issue":"2","key":"10.1016\/j.berh.2016.10.004_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/rheumatology\/kel253","article-title":"Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis","volume":"46","author":"Young","year":"2007","journal-title":"Rheumatol Oxf"},{"issue":"9","key":"10.1016\/j.berh.2016.10.004_bib6","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics\u2014a large multicentre UK study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.berh.2016.10.004_bib7","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.rmed.2012.04.004","article-title":"Rheumatoid lung disease: prognostic analysis of 54 biopsy-proven cases","volume":"106","author":"Nakamura","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.berh.2016.10.004_bib8","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.4187\/respcare.02597","article-title":"Pleuro-pulmonary complications of rheumatoid arthritis","volume":"59","author":"Corcoran","year":"2014","journal-title":"Respir Care"},{"issue":"2","key":"10.1016\/j.berh.2016.10.004_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","article-title":"American thoracic society\/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias","volume":"165","author":"American Thoracic Society\/European Respiratory Society","year":"2002","journal-title":"Am J Res Crit Care Med"},{"issue":"6","key":"10.1016\/j.berh.2016.10.004_bib10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/ard.61.6.517","article-title":"Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis","volume":"61","author":"Dawson","year":"2002","journal-title":"Ann Rheumatic Dis"},{"issue":"8","key":"10.1016\/j.berh.2016.10.004_bib11","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/thorax.56.8.622","article-title":"Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests","volume":"56","author":"Dawson","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.berh.2016.10.004_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/872120","article-title":"Rheumatoid arthritis-associated interstitial lung disease: diagnostic dilemma","volume":"2011","author":"Hamblin","year":"2011","journal-title":"Pulm Med"},{"issue":"6","key":"10.1016\/j.berh.2016.10.004_bib13","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1378\/chest.127.6.2019","article-title":"Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease","volume":"127","author":"Lee","year":"2005","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.berh.2016.10.004_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1148\/radiol.2321030174","article-title":"Rheumatoid arthritis-related lung diseases: CT findings","volume":"232","author":"Tanaka","year":"2004","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.berh.2016.10.004_bib15","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1378\/chest.09-0444","article-title":"Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern","volume":"136","author":"Kim","year":"2009","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.berh.2016.10.004_bib16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1148\/radiol.13130187","article-title":"Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern","volume":"270","author":"Assayag","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.berh.2016.10.004_bib17","first-page":"759760","article-title":"The multifaceted aspects of interstitial lung disease in rheumatoid arthritis","author":"Cavagna","year":"2013","journal-title":"BioMed Res Int"},{"issue":"02","key":"10.1016\/j.berh.2016.10.004_bib18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-0034-1371542","article-title":"Rheumatoid arthritis and lung disease: from mechanisms to a practical approach","volume":"35","author":"Lake","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.berh.2016.10.004_bib19","article-title":"Interstitial lung disease in rheumatoid arthritis: a review Arthritis Research","volume":"7","author":"Chan","year":"2013","journal-title":"Top Rev Ser"},{"issue":"3","key":"10.1016\/j.berh.2016.10.004_bib20","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1378\/chest.13-2408","article-title":"A\u00a0roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung disease","volume":"145","author":"Doyle","year":"2014","journal-title":"Chest"},{"issue":"Suppl. 5","key":"10.1016\/j.berh.2016.10.004_bib21","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1136\/thx.2008.101691","article-title":"Interstitial lung disease guideline","volume":"63","author":"Wells","year":"2008","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.berh.2016.10.004_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1164\/rccm.201202-0314OC","article-title":"A\u00a0placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis","volume":"186","author":"Noth","year":"2012","journal-title":"Am J Respir Crit care Med"},{"issue":"3","key":"10.1016\/j.berh.2016.10.004_bib23","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1378\/chest.128.3.1475","article-title":"Anticoagulant therapy for idiopathic pulmonary fibrosis","volume":"128","author":"Kubo","year":"2005","journal-title":"Chest"},{"issue":"21","key":"10.1016\/j.berh.2016.10.004_bib24","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1056\/NEJMoa042976","article-title":"High-dose acetylcysteine in idiopathic pulmonary fibrosis","volume":"353","author":"Demedts","year":"2005","journal-title":"N.\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.berh.2016.10.004_bib25","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1401739","article-title":"Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis","volume":"370","author":"The Idiopathic Pulmonary Fibrosis Clinical Research Network","year":"2014","journal-title":"N.\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2016.10.004_bib26","article-title":"Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case\u2013control analysis","volume":"2012","author":"Dixon","year":"2012","journal-title":"Ann Rheumatic Dis"},{"issue":"25","key":"10.1016\/j.berh.2016.10.004_bib27","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N.\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.berh.2016.10.004_bib28","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1164\/rccm.200702-326OC","article-title":"Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease","volume":"176","author":"Tashkin","year":"2007","journal-title":"Am J Respir Crit care Med"},{"issue":"5","key":"10.1016\/j.berh.2016.10.004_bib29","doi-asserted-by":"crossref","first-page":"R124","DOI":"10.1186\/ar2534","article-title":"Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies","volume":"10","author":"Nannini","year":"2008","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.berh.2016.10.004_bib30","first-page":"293","article-title":"Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase","volume":"25","author":"Airo","year":"2007","journal-title":"Clin Exp rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2016.10.004_bib31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00296-006-0217-1","article-title":"Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease","volume":"27","author":"Yiannopoulos","year":"2007","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.berh.2016.10.004_bib32","first-page":"355","article-title":"Rheumatoid arthritis associated with methotrexate-induced pneumonitis: improvement with iv cyclophosphamide therapy","volume":"17","author":"Suwa","year":"1998","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2016.10.004_bib33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0012-3692(15)50949-5","article-title":"Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease","volume":"130","author":"Swigris","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.berh.2016.10.004_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1155\/2012\/143637","article-title":"Effect and safety of mycophenolate mofetil or sodium in systemic sclerosis-associated interstitial lung disease: a meta-analysis","volume":"2012","author":"Tzouvelekis","year":"2012","journal-title":"Pulm Med"},{"issue":"5","key":"10.1016\/j.berh.2016.10.004_bib35","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3899\/jrheum.121043","article-title":"Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease","volume":"40","author":"Fischer","year":"2013","journal-title":"J\u00a0rheumatology"},{"issue":"15","key":"10.1016\/j.berh.2016.10.004_bib36","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1001\/archinte.168.15.1718","article-title":"Rheumatoid arthritis interstitial lung disease: mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug","volume":"168","author":"Saketkoo","year":"2008","journal-title":"Archives Intern Med"},{"issue":"5","key":"10.1016\/j.berh.2016.10.004_bib37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MAJ.0b013e31818d094b","article-title":"Experience of mycophenolate mofetil in 10 patients with autoimmune-related interstitial lung disease demonstrates promising effects","volume":"337","author":"Saketkoo","year":"2009","journal-title":"Am J Med Sci"},{"issue":"18","key":"10.1016\/j.berh.2016.10.004_bib38","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1517\/14656560802591430","article-title":"Treatment strategies for a rheumatoid arthritis patient with interstitial lung disease","volume":"9","author":"Kelly","year":"2008","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"10.1016\/j.berh.2016.10.004_bib39","first-page":"i99","article-title":"The effect of steroids, azathioprine and Mycophenolate on the risk of death in rheumatoid arthritis","volume":"55","author":"Kelly","year":"2016","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2016.10.004_bib40","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/pds.3409","article-title":"Association between anti-TNF-\u03b1 therapy and interstitial lung disease","volume":"22","author":"Herrinton","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"10.1016\/j.berh.2016.10.004_bib41","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.semarthrit.2013.09.005","article-title":"Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review","volume":"43","author":"Roubille","year":"2014","journal-title":"Sem Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2016.10.004_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5499\/wjr.v5.i1.1","article-title":"Interstitial lung disease in rheumatoid arthritis: current concepts in pathogenesis, diagnosis and therapeutics","volume":"5","author":"Olivas-Flores","year":"2015","journal-title":"World J Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2016.10.004_bib43","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/art.21758","article-title":"Morphologic and quantitative assessment of CD20+ B cell infiltrates in rheumatoid arthritis\u2013associated nonspecific interstitial pneumonia and usual interstitial pneumonia","volume":"54","author":"Atkins","year":"2006","journal-title":"Arthritis Rheu"},{"issue":"1","key":"10.1016\/j.berh.2016.10.004_bib44","first-page":"i86","article-title":"Survival in rheumatoid lung disease is longer in patients treated with rituximab than in those receiving anti tumour necrosis factor therapy","volume":"55","author":"Iqbal","year":"2016","journal-title":"Rheumatology"},{"issue":"Suppl. 1","key":"10.1016\/j.berh.2016.10.004_bib45","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1465-9921-14-S1-S5","article-title":"The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis","volume":"14","author":"Cottin","year":"2013","journal-title":"Respir Res"},{"issue":"1","key":"10.1016\/j.berh.2016.10.004_bib46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1164\/rccm.200705-732OC","article-title":"BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis","volume":"177","author":"King","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.berh.2016.10.004_bib47","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.healun.2014.01.858","article-title":"Survival and quality of life in rheumatoid arthritis-associated interstitial lung disease after lung transplantation","volume":"33","author":"Yazdani","year":"2014","journal-title":"J\u00a0Heart Lung Transp Off Publ Int Soc Heart Transp"},{"issue":"8","key":"10.1016\/j.berh.2016.10.004_bib48","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","article-title":"Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort","volume":"49","author":"Koduri","year":"2010","journal-title":"Rheumatol Oxf"},{"issue":"10","key":"10.1016\/j.berh.2016.10.004_bib49","first-page":"531","article-title":"Prevalence of symptomatic bronchiectasis in patients with rheumatoid arthritis","volume":"64","author":"Allain","year":"1997","journal-title":"Rev Rhum Engl Ed"},{"issue":"10","key":"10.1016\/j.berh.2016.10.004_bib50","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/ard.54.10.815","article-title":"Use of high resolution computed tomography of the lungs in patients with rheumatoid arthritis","volume":"54","author":"Cortet","year":"1995","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.berh.2016.10.004_bib51","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/ard.54.4.308","article-title":"High resolution computed tomography of the lung in lifelong non-smoking patients with rheumatoid arthritis","volume":"54","author":"Hassan","year":"1995","journal-title":"Ann Rheum Dis"},{"issue":"4933","key":"10.1016\/j.berh.2016.10.004_bib52","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/bmj.2.4933.228","article-title":"Lung lesions in rheumatoid arthritis","volume":"2","author":"Aronoff","year":"1955","journal-title":"Br Med J"},{"issue":"10","key":"10.1016\/j.berh.2016.10.004_bib53","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/rheumatology\/31.10.691","article-title":"Bronchiectasis and rheumatoid disease: is there an association?","volume":"31","author":"Solanki","year":"1992","journal-title":"Br J Rheumatol"},{"issue":"142","key":"10.1016\/j.berh.2016.10.004_bib54","first-page":"239","article-title":"Pulmonary infections and rheumatoid arthritis","volume":"36","author":"Walker","year":"1967","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.berh.2016.10.004_bib55","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4187\/respcare.01857","article-title":"Coexistence of bronchiectasis and rheumatoid arthritis: revisited","volume":"58","author":"Wilczynska","year":"2013","journal-title":"Respir Care"},{"issue":"1","key":"10.1016\/j.berh.2016.10.004_bib56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/03009748509102010","article-title":"Rheumatoid arthritis and chronic bronchial suppuration","volume":"14","author":"Bamji","year":"1985","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2016.10.004_bib57","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00005792-199405000-00005","article-title":"Bronchiectasis. A late feature of severe rheumatoid arthritis","volume":"73","author":"Shadick","year":"1994","journal-title":"Med Baltim"},{"key":"10.1016\/j.berh.2016.10.004_bib58","first-page":"125","article-title":"Younger onset of rheumatoid arthritis in patients with bronchiectasis","volume":"32","author":"McMahon","year":"1993","journal-title":"Br J Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2016.10.004_bib59","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/art.34344","article-title":"Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity?","volume":"64","author":"Demoruelle","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2016.10.004_bib60","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1183\/09031936.00064014","article-title":"RA autoantibodies as predictors of rheumatoid arthritis in non-cystic fibrosis bronchiectasis patients","volume":"44","author":"Perry","year":"2014","journal-title":"Eur Resp J"},{"issue":"11","key":"10.1016\/j.berh.2016.10.004_bib61","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/rheumatology\/keu195","article-title":"The lung in ACPA-positive rheumatoid arthritis: an initiating site of injury?","volume":"53","author":"Perry","year":"2014","journal-title":"Rheumatol"},{"key":"10.1016\/j.berh.2016.10.004_bib62","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1378\/chest.116.4.1063","article-title":"Bronchiectasis in systemic diseases","volume":"116","author":"Cohen","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.berh.2016.10.004_bib63","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1183\/09031936.99.13612889","article-title":"Increased frequency of cystic fibrosis DF508 mutation in bronchiectasis associated with rheumatoid arthritis","volume":"13","author":"Puechal","year":"1999","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.berh.2016.10.004_bib64","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1136\/ard.2003.015123","article-title":"Association between bronchiectasis and smoking in patients with rheumatoid arthritis","volume":"63","author":"Kaushik","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2016.10.004_bib65","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1148\/radiology.193.2.7972746","article-title":"Lung changes in rheumatoid arthritis: CT findings","volume":"193","author":"Remy-Jardin","year":"1994","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.berh.2016.10.004_bib66","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00296-004-0472-y","article-title":"Pulmonary involvement in rheumatoid arthritis","volume":"25","author":"Bilgici","year":"2005","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.berh.2016.10.004_bib67","first-page":"i104","article-title":"Efficacy of rituximab in patients with rheumatoid arthritis associated with bronchiectasis: results from a multi centre cohort","volume":"55","author":"Iqbal","year":"2016","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2016.10.004_bib68","first-page":"i103","article-title":"Safety of rituximab in patients with rheumatoid arthritis associated with bronchiectasis: results from a multi centre cohort","volume":"55","author":"Yuzaufal","year":"2016","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2016.10.004_bib69","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1479972310391282","article-title":"Effects of pulmonary rehabilitation in bronchiectasis: a retrospective study","volume":"8","author":"Ong","year":"2011","journal-title":"Chron Respir Dis"},{"key":"10.1016\/j.berh.2016.10.004_bib70","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/rheumatology\/kel332","article-title":"What kills patients with rheumatoid arthritis?","volume":"46","author":"Kelly","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2016.10.004_bib71","first-page":"1832","article-title":"Acute lower respiratory tract infections in patients with rheumatoid arthritis","volume":"34","author":"Coyne","year":"2007","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2016.10.004_bib72","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.10524","article-title":"Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study","volume":"46","author":"Doran","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.004_bib73","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/rheumatology\/kep325","article-title":"Initiation of rheumatoid arthritis treatments and the risk of serious infections","volume":"49","author":"Grijalva","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2016.10.004_bib74","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/art.21568","article-title":"Treatment for rheumatoid arthritis and the risk of hospitalisation for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs and anti-tumour necrosis factor therapy","volume":"54","author":"Wolfe","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.004_bib75","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7861\/clinmedicine.10-4-326","article-title":"How to reduce morbidity and mortality from chest infections in rheumatoid arthritis","volume":"4","author":"Housden","year":"2010","journal-title":"Clin Med"},{"key":"10.1016\/j.berh.2016.10.004_bib76","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/rheumatology\/kei193","article-title":"Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis","volume":"45","author":"Kapetanovic","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2016.10.004_bib77","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1136\/ard.2010.144451","article-title":"Pneumococcal antibody levels after pneumovax in patients with rheumatoid arthritis on methotrexate","volume":"70","author":"Coulson","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.berh.2016.10.004_bib78","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/RHU.0000000000000244","article-title":"Pleural effusion, pneumothorax, and lung entrapment in rheumatoid arthritis","volume":"21","author":"Komarla","year":"2015","journal-title":"J\u00a0Clin Rheumatol"},{"key":"10.1016\/j.berh.2016.10.004_bib79","series-title":"Lung disease in rheumatic disorders","first-page":"1","article-title":"Rheumatoid arthritis: classical lung disease","author":"Kelly","year":"1993"},{"key":"10.1016\/j.berh.2016.10.004_bib80","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.semarthrit.2006.03.002","article-title":"Rheumatoid pleural effusion","volume":"35","author":"Balbir-Gurman","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.004_bib81","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/03009748209098194","article-title":"Prevalence of pulmonary involvement in rheumatoid arthritis and its relationship to some characteristics of the patients","volume":"11","author":"Juric","year":"1982","journal-title":"A\u00a0radiological Clin study Scand J Rheumatol"},{"key":"10.1016\/j.berh.2016.10.004_bib82","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/ard.26.6.467","article-title":"Rheumatoid pleuritis","volume":"26","author":"Walker","year":"1967","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.004_bib83","series-title":"BTS pleural disease guideline","author":"British Thoracic Society","year":"2010"},{"key":"10.1016\/j.berh.2016.10.004_bib84","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/thx.40.5.371","article-title":"Thoracoscopic, histological, and clinical findings in nine case rheumatoid pleural effusion","volume":"40","author":"Faurschou","year":"1985","journal-title":"Thorax"},{"key":"10.1016\/j.berh.2016.10.004_bib85","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1378\/chest.100.1.235","article-title":"Pulmonary manifestations associated with rheumatoid arthritis","volume":"100","author":"Helmers","year":"1991","journal-title":"Chest"},{"issue":"24","key":"10.1016\/j.berh.2016.10.004_bib86","first-page":"1642","article-title":"Case records of the Massachusetts general hospital","volume":"331","author":"Anderson","year":"1994","journal-title":"N\u00a0Eng J Med"},{"key":"10.1016\/j.berh.2016.10.004_bib87","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-31-2-216","article-title":"Pulmonary disease manifestations of ankylosing spondylitis","volume":"31","author":"Hamilton","year":"1949","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.berh.2016.10.004_bib88","first-page":"641","article-title":"Pleuropulmonary manifestations of ankylosing spondylitis","volume":"52","author":"Rosenow","year":"1977","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.berh.2016.10.004_bib89","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1590\/abd1806-4841.20164169","article-title":"Psoriasis: new comorbidities","volume":"91","author":"Machado-Pinto","year":"2016","journal-title":"An Bras Dermatol"},{"issue":"1","key":"10.1016\/j.berh.2016.10.004_bib90","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1468-3083.2011.04009.x","article-title":"Association between psoriasis and chronic obstructive pulmonary disease: a population-based study in Taiwan","volume":"26","author":"Chiang","year":"2012","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.berh.2016.10.004_bib91","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamadermatol.2013.5015","article-title":"Psoriasis severity and the prevalence of major medical comorbidity: a population-based study","volume":"149","author":"Yeung","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.berh.2016.10.004_bib92","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1365-2133.2008.08749.x","article-title":"Psoriasis and chronic obstructive pulmonary disease: a case-control study","volume":"159","author":"J1","year":"2008","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.berh.2016.10.004_bib93","doi-asserted-by":"crossref","first-page":"e0145221","DOI":"10.1371\/journal.pone.0145221","article-title":"Association between psoriasis and chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.berh.2016.10.004_bib94","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/jamadermatol.2013.4256","article-title":"Sarcoidosis and psoriasis: a case series and review of the literature exploring co-incidence vs coincidence","volume":"149","author":"Wanat","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.berh.2016.10.004_bib95","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2466-6-26","article-title":"Pulmonary sarcoidosis associated with psoriasis vulgaris: coincidental occurrence or causal association? Case report","volume":"6","author":"Nikolopoulou","year":"2006","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.berh.2016.10.004_bib96","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10067-014-2652-9","article-title":"Extra articular manifestations in psoriatic arthritis patients","volume":"34","author":"Peluso","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2016.10.004_bib97","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/art.1780401021","article-title":"Mortality studies in psoriatic arthritis. Results from a single centre. I. Risk and causes of death","volume":"40","author":"Wong","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.004_bib98","doi-asserted-by":"crossref","first-page":"h1269","DOI":"10.1136\/bmj.h1269","article-title":"Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials","volume":"350","author":"Conway","year":"2015","journal-title":"BMJ Br Med J"},{"key":"10.1016\/j.berh.2016.10.004_bib99","unstructured":"Camus P. The drug-induced respiratory disease website. www.pneumotox.com (Accessed on 21 April 2016)."},{"key":"10.1016\/j.berh.2016.10.004_bib100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1034\/j.1399-3003.2000.15b25.x","article-title":"Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients","volume":"15","author":"Imokawa","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.berh.2016.10.004_bib101","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7326\/0003-4819-127-5-199709010-00003","article-title":"Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group","volume":"127","author":"Alarc\u00f3n","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.berh.2016.10.004_bib102","first-page":"51","article-title":"Can baseline pulmonary functions tests predict pulmonary toxicity in patients receiving methotrexate for rheumatoid arthritis?","volume":"7","author":"Howes","year":"1999","journal-title":"Intern Med"},{"issue":"7","key":"10.1016\/j.berh.2016.10.004_bib103","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/ard.53.7.434","article-title":"Methotrexate-related pulmonary complications in rheumatoid arthritis","volume":"53","author":"Barrera","year":"1994","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2016.10.004_bib104","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/art.22666","article-title":"Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis","volume":"56","author":"Ju","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.berh.2016.10.004_bib105","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/rheumatology\/kep050","article-title":"Clinical expression of leflunomide-induced pneumonitis","volume":"48","author":"Chikura","year":"2009","journal-title":"Rheumatol Oxf"},{"issue":"3","key":"10.1016\/j.berh.2016.10.004_bib106","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s10067-005-0024-1","article-title":"Rheumatoid lung nodulosis and osteopathy associated with leflunomide therapy","volume":"25","author":"Rozin","year":"2006","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2016.10.004_bib107","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12253-008-9003-6","article-title":"Intrapulmonary rheumatoid nodules in a patient with long-standing rheumatoid arthritis treated with leflunomide","volume":"14","author":"Horvath","year":"2008","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.berh.2016.10.004_bib108","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1038\/cdd.2010.64","article-title":"Induction of EMT-like phenotypes by an active metabolite of leflunomide and its contribution to pulmonary fibrosis","volume":"17","author":"Namba","year":"2010","journal-title":"Cell Death Differ"},{"issue":"4","key":"10.1016\/j.berh.2016.10.004_bib109","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1183\/09031936.02.00267402","article-title":"Sulphasalazine and lung toxicity","volume":"19","author":"Parry","year":"2002","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.berh.2016.10.004_bib110","first-page":"65","article-title":"Severe drug hypersensitivity syndrome due to sulphasalazine in patient with rheumatoid arthritis","volume":"61","author":"Gutierrez","year":"2009","journal-title":"Reumatismo"},{"issue":"1","key":"10.1016\/j.berh.2016.10.004_bib111","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jbspin.2004.06.002","article-title":"DRESS syndrome in a patient on sulfasalazine for rheumatoid arthritis","volume":"72","author":"Michel","year":"2005","journal-title":"Jt Bone Spine"},{"issue":"3","key":"10.1016\/j.berh.2016.10.004_bib112","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1164\/ajrccm.155.3.9116980","article-title":"Gold-induced pulmonary disease: clinical features, outcome, and differentiation from rheumatoid lung disease","volume":"155","author":"Tomioka","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.berh.2016.10.004_bib113","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0272-5231(05)70118-0","article-title":"Pulmonary toxicity of drugs used to treat systemic autoimmune diseases","volume":"19","author":"Libby","year":"1998","journal-title":"Clin Chest Med"},{"issue":"1","key":"10.1016\/j.berh.2016.10.004_bib114","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/art.1780280115","article-title":"Beneficial effect of intravenous cyclophosphamide and oral prednisone on D-penicillamine-associated bronchiolitis obliterans","volume":"28","author":"van de Laar","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.004_bib115","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semarthrit.2010.11.002","article-title":"Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases","volume":"41","author":"Perez-Alvarez","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.004_bib116","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1093\/rheumatology\/ker289","article-title":"Non-infectious pulmonary complications of newer biological agents for rheumatic diseases \u2013 a systematic literature review","volume":"50","author":"Hadjinicolaou","year":"2011","journal-title":"Rheumatol Oxf"},{"key":"10.1016\/j.berh.2016.10.004_bib117","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/1479972310393758","article-title":"Review series: aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?","volume":"8","author":"de Lauretis","year":"2011","journal-title":"Chron Respir Dis"},{"key":"10.1016\/j.berh.2016.10.004_bib118","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s40265-014-0190-z","article-title":"Interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug induced","volume":"74","author":"Hallowell","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.berh.2016.10.004_bib119","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ctrv.2005.05.007","article-title":"Tolerability and safety of rituximab (MabThera)","volume":"31","author":"Kimby","year":"2005","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.berh.2016.10.004_bib120","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/resp.12214","article-title":"Rituximab in severe, treatment-refractory interstitial lung disease","volume":"19","author":"Keir","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/j.berh.2016.10.004_bib121","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","article-title":"Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial","volume":"371","author":"Smolen","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2016.10.004_bib122","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1007\/s00296-010-1525-z","article-title":"A\u00a0fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab","volume":"32","author":"Kawashiri","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2016.10.004_bib123","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jbspin.2013.03.009","article-title":"Exacerbation of combined pulmonary fibrosis and emphysema syndrome during tocilizumab therapy for rheumatoid arthritis","volume":"80","author":"Wendling","year":"2013","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.berh.2016.10.004_bib124","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2177\/jsci.35.433","article-title":"A\u00a0case of rheumatoid arthritis complicated with deteriorated interstitial pneumonia after the administration of abatacept","volume":"35","author":"Wada","year":"2012","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"issue":"1360","key":"10.1016\/j.berh.2016.10.004_bib125","first-page":"74","article-title":"Pulmonary infiltrates with eosinophilia syndrome in ibuprofen overdose","volume":"125","author":"Vogts","year":"2012","journal-title":"N\u00a0Z Med J"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694216300778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694216300778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T06:27:42Z","timestamp":1601188062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694216300778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":125,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1521694216300778"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2016.10.004","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lung involvement in inflammatory rheumatic diseases","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2016.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2016 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}